Nebenwirkungen · Gardasil
Gardasil suspension for injection. Gardasil suspension for injection in a pre-filled syringe. Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed). · Abschnitt 4.8 · PDF-Seite 6
HOS-116245 · Präparat HOS-094431
Post-Marketing Experience Table 1 also includes additional adverse events which have been spontaneously reported during the post-marketing use of Gardasil worldwide. Because these events are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to vaccine exposure. Consequently, the frequency of these adverse events is qualified as "not known".
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-10-20T11:35:00Z · SHA-256 e89fa50e1a391a8c065f4028bfd1c63d5aeb15de9278e038e79343ad89ef236e · Passage af07ee1d4893e2d0eaaea7a0f5742d3ca0e7fe84d57b59bf5ef0c8c1e43e0297 · Zeichen 1568–2016 im Abschnitt